ATE316577T1 - Das goodpasture-antigen bindende protein - Google Patents

Das goodpasture-antigen bindende protein

Info

Publication number
ATE316577T1
ATE316577T1 AT00911146T AT00911146T ATE316577T1 AT E316577 T1 ATE316577 T1 AT E316577T1 AT 00911146 T AT00911146 T AT 00911146T AT 00911146 T AT00911146 T AT 00911146T AT E316577 T1 ATE316577 T1 AT E316577T1
Authority
AT
Austria
Prior art keywords
antigen binding
binding protein
gpbp
goodpasture antigen
goodpasture
Prior art date
Application number
AT00911146T
Other languages
English (en)
Inventor
Juan Saus
Original Assignee
Juan Saus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22397008&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE316577(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Juan Saus filed Critical Juan Saus
Application granted granted Critical
Publication of ATE316577T1 publication Critical patent/ATE316577T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
    • C12Y207/01037—Protein kinase (2.7.1.37)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00911146T 1999-02-24 2000-02-24 Das goodpasture-antigen bindende protein ATE316577T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12148399P 1999-02-24 1999-02-24

Publications (1)

Publication Number Publication Date
ATE316577T1 true ATE316577T1 (de) 2006-02-15

Family

ID=22397008

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00911146T ATE316577T1 (de) 1999-02-24 2000-02-24 Das goodpasture-antigen bindende protein

Country Status (10)

Country Link
US (5) US6579969B1 (de)
EP (1) EP1144650B1 (de)
JP (1) JP3761784B2 (de)
AT (1) ATE316577T1 (de)
AU (1) AU760197B2 (de)
CA (1) CA2361987C (de)
DE (1) DE60025704T2 (de)
ES (1) ES2254151T3 (de)
MX (1) MXPA01008605A (de)
WO (1) WO2000050607A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7060459B2 (en) 2000-12-08 2006-06-13 Juan Saus TNF-inducible promoters and methods for using
US6881547B1 (en) * 2001-01-31 2005-04-19 Juan Saus Methods and reagents for treating autoimmune disorders
US7147855B2 (en) 2001-12-07 2006-12-12 Juan Saus GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
WO2004070025A2 (en) * 2003-02-05 2004-08-19 Juan Saus Novel goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
JP2005035926A (ja) * 2003-07-14 2005-02-10 Japan Science & Technology Agency セラミド輸送を促進する薬剤、該薬剤を製造する塩基配列、セラミド遊離を促進する活性の測定方法、及びセラミドの膜間移動を促進する活性の測定方法
SI2126093T1 (sl) * 2007-03-02 2013-01-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Izboljšanje priprave proteinov
US9566768B2 (en) 2007-12-17 2017-02-14 Kureha Corporation Thermally shrinkable laminate film for deep drawing, packaged article, and method for packaging of cheese
ES2535258T3 (es) * 2008-07-22 2015-05-07 Fibrostatin, Sociedad Limitada Proteína de unión al antígeno de Goodpasture y su detección
JP2012525826A (ja) 2009-05-05 2012-10-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｈｏ／ｃｅｒｔ細胞系
CN102781898B (zh) * 2009-11-05 2014-12-24 菲布他丁有限合伙公司 使用q2拟肽的gpbp抑制
WO2012113785A1 (en) 2011-02-21 2012-08-30 Fibrostatin S.L. Methods for treating and diagnosing disease
JP2015524385A (ja) 2012-07-02 2015-08-24 フィブロスタティン，エス．エル． Ｇｐｂｐ−１阻害およびその治療的使用
US20160184274A1 (en) 2014-12-31 2016-06-30 Fibrostatin, S.L. Methods for inhibiting mesenchymal phenotype after epithelial-to-mesenchymal transition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424408A (en) * 1990-11-30 1995-06-13 Yale University α-3 chain type IV collagen polynucleotides
US6007980A (en) 1990-11-30 1999-12-28 Yale University Alpha-3 chain type IV collagen polypeptides
WO1993016179A1 (en) * 1992-02-17 1993-08-19 Howard Florey Institute Of Experimental Physiology And Medicine MAMMALIAN Sos - A REGULATOR/EFFECTOR OF TYROSINE KINASE SIGNALLING
US5716622A (en) * 1995-01-06 1998-02-10 The Rockefeller University Functionally active regions of signal transducer and activators of transcription
US6045997A (en) * 1995-11-23 2000-04-04 Duke University Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof

Also Published As

Publication number Publication date
US7629132B2 (en) 2009-12-08
US6579969B1 (en) 2003-06-17
ES2254151T3 (es) 2006-06-16
WO2000050607A3 (en) 2000-11-30
US7189517B2 (en) 2007-03-13
CA2361987C (en) 2007-07-03
JP2003525023A (ja) 2003-08-26
DE60025704T2 (de) 2006-09-07
EP1144650B1 (de) 2006-01-25
US20070178540A1 (en) 2007-08-02
DE60025704D1 (de) 2006-04-13
WO2000050607A2 (en) 2000-08-31
AU3314000A (en) 2000-09-14
MXPA01008605A (es) 2003-06-24
AU760197B2 (en) 2003-05-08
US20100247553A1 (en) 2010-09-30
EP1144650A2 (de) 2001-10-17
US7186527B2 (en) 2007-03-06
JP3761784B2 (ja) 2006-03-29
CA2361987A1 (en) 2000-08-31
US20030049791A1 (en) 2003-03-13
US20030054488A1 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
EP1187591A4 (de) Mit entzündlichen darmerkrankungen (ibd) assoziierte mikrobielle antigene und verfahren derer anwendung
DK1093517T3 (da) Neisseria-meningitidis-antigener og præparater
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
TR199701462T1 (xx) DNA Dizisi ve bununla kodlanm�� meme'ye �zel g���s kanseri proteini.
BRPI0411854A (pt) veìculos protéicos para vacinas
DK1131444T3 (da) Polypeptider med lysophospholipase aktivitet og nucleinsyre som koder for disse
DE60025704D1 (de) Das goodpasture-antigen bindende protein
DK1025236T3 (da) Human checkpoint kinase, HCDS1, præparater og fremgangsmåde
DE60315827D1 (de) Verbesserte polysaccharid- und glykokonjugat-vakzine
DE60139544D1 (de) Veränderte, fluoreszierende proteine
BR9710919A (pt) Proteina purificada sr-p70
WO2002026929A3 (en) Kini-3 motor protein and methods for its use
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
NO20024779L (no) G-protein-koblet reseptor
WO2002012541A3 (en) Novel motor proteins and methods for their use
WO2001096593A3 (en) Novel motor proteins and methods for their use
WO2001083524A3 (en) Rna metabolism proteins
WO2003025134A3 (en) mcFP ENCODING NUCLEIC ACIDS, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE THEREOF
WO2002046378A3 (en) Alternative pol k nucleotide and amino acid sequence and methods for using
WO2001065262A3 (en) Reagents and methods useful for detecting diseases of the breast
WO2003004678A3 (en) Novel receptors
WO2004065554A3 (en) Human saa3 nucleic acid molecule, protein, and methods of use for same
NO20011961D0 (no) PRV-1-genet og anvendelsen av dette
WO2002038765A3 (en) Dna encoding bovine immunoglobulin a inducing protein and uses therefor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties